alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
C. Options 

1. All Amendments to Provide for and Encourage Electronic Reporting Are 

Included in CROMERRR 

Do not amend each Part of the CFR; address the electronic reporting and record-keeping issues 

only in CROMERRR. Include provisions in a CROMERRR to effectuate global revisions 

across all programs. These provisions should: 

Include in the CROMERRR a rule of construction that allows electronic reporting 

and record keeping in conformance with the CROMERRR wherever there is a 

reporting requirement in all 24 volumes of the CFR. 

Add provisions and definitions to CROMERRR that would effectuate a wholesale 

revision of terms and procedures in all 24 volumes of the regulations to include 

electronic recordkeeping and reporting in conformance with the CROMERRR. 

2. All Amendments Occur in Parts Other than CROMERRR 

a. Amend Each Section, Subsection, and Appendix of the CFR that Contains 

Definitions, Procedures, and Instructions 

This is impractical; there were approximately 100,000 hits for words on our list. More 

efficient would be to amend at a Subpart or Part level. 

b. Amend each Subpart in which there Are Electronic Reporting Requirements 

This approach is possible and is still a prodigious effort. There are approximately 1600 

Subparts in the CFR. Not all contain reporting requirements, yet even if we just amend 

those Subparts that contain reporting requirements; this is a lot of amendments. 

c. Amend each Part in which there Are Electronic Reporting Requirements 

This involves a more manageable number of amendments; however, this is inflexible. A 

more flexible approach would be to adopt a hybrid where some amendments occur at the 

Part level and provisions are inserted in CROMERRR that would facilitate a transition to 

electronic reporting in all Parts. 

c 
I r 

3. Mixed Approach - Some Amendments in CROMERRR Other Amendments in 

Other Parts of CFR 

Amend Parts of the CFR to state that electronic reporting in accordance with 

CROMERRR is encouraged. 

Amend the problematic definitions (they are relatively few in number). 

Adopt a rule of construction for each Part for reporting requirements. The rule of 

construction should provide that provisions involving reporting can be construed as 

allowing electronic reporting in conformance with A rule of construction can help 

address both common usage and explicit definition issues. 

Add new definitions both in CROMERRR and in each Part that make explicit that a 

laundry list of words (serve, transmit, submit, address, consent, certification, file, etc....) 

when used in connection with reporting they shall include electronic means in accordance 

with CROMERRR.
<PAGE>
                                                                    EXHIBIT 24.9



                               POWER OF ATTORNEY


The undersigned director and/or officer of Karrington Health, Inc. (the
"Company"), does hereby constitute and appoint Richard R. Slager and Alan B.
Satterwhite, or either of them, my true and lawful attorneys and agents, each
with full power of substitution, to do any and all acts and things in my name
and on my behalf in my capacity as a director of the Company and to execute
any and all instruments for me and in my name in the capacity indicated
above, which said attorneys or agents, or either of them, may deem necessary
or advisable to enable the Company to comply with the Securities Exchange Act
of 1934, as amended, and any rules, regulations and requirements of the
Securities and Exchange Commission thereunder, in connection with the filing
requirements of the Company's Annual Report on Form 10-K for the fiscal year
ended December 31, 1996 (the "1996 Form 10-K"), including specifically but
without limitation, power and authority to sign for me in my name, in the
capacity indicated above, the 1996 Form 10-K and any and all amendments to
such 1996 Form 10-K; and I do hereby ratify and confirm all that the said
attorneys and agents, or their substitute or substitutes, or either of them,
shall do or cause to be done by virtue hereof.

                                        /S/ JAMES V. PICKETT
                                        ---------------------
                                        James V. Pickett
                                        Director
EXHIBIT 31.2

CERTIFICATIONS

I,
Bernard F. Denoyer, certify that:

1)    I
have reviewed this quarterly report on Form 10-Q of Callisto Pharmaceuticals, Inc.

2)    Based
on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3)    Based
on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial
condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

4)    The
registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-14 and 15d-14) for the registrant and we have:



5)    The
registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's
auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions);



|Date: November 14, 2007 | /s/BERNARD F. DENOYERBernard F. Denoyer Vice President, Finance
|----------------------- | ---------------------------------------------------------------

---



QuickLinks
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          SEP-30-1996
<PERIOD-START>                             OCT-01-1995
<PERIOD-END>                               DEC-31-1995
<CASH>                                       3,081,000
<SECURITIES>                                         0
<RECEIVABLES>                                1,913,100
<ALLOWANCES>                                   150,000
<INVENTORY>                                    496,400
<CURRENT-ASSETS>                             5,432,100
<PP&E>                                       1,516,200
<DEPRECIATION>                               1,085,400
<TOTAL-ASSETS>                               6,131,900
<CURRENT-LIABILITIES>                        1,857,300
<BONDS>                                              0
<COMMON>                                         1,900
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                   4,274,600
<TOTAL-LIABILITY-AND-EQUITY>                 6,131,900
<SALES>                                      3,328,600
<TOTAL-REVENUES>                             3,328,600
<CGS>                                        1,558,900
<TOTAL-COSTS>                                1,558,900
<OTHER-EXPENSES>                             1,504,900
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                264,800
<INCOME-TAX>                                   103,300
<INCOME-CONTINUING>                            161,500
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   161,500
<EPS-PRIMARY>                                      .08
<EPS-DILUTED>                                      .08
        

</TABLE>
### UNPUBLISHED



# UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT



#  U NITED S TATES OFA MERICA ,

Plaintiff-Appellee,

v. No. 02-4009



# 
R ICARDO L AMONT R AY ,

Defendant-Appellant. 

# 
Appeal from the United States District Court for the Eastern District of Virginia, at Norfolk. Jerome B. Friedman, District Judge.

(CR-01-139) Submitted: June 24, 2002 Decided: July 18, 2002 Before WIDENER, MICHAEL, and TRAXLER, Circuit Judges.

Dismissed by unpublished per curiam opinion.

COUNSELPaul A. Driscoll, PENDER & COWARD, P.C., Virginia Beach, Virginia, for Appellant. Paul J. McNulty, United States Attorney, Joseph E. DePadilla, Assistant United States Attorney, Norfolk, Virginia, for Appellee.

Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).OPINION
PER CURIAM: Pursuant to a valid plea agreement, Ricardo Lamont Ray pled guilty to possession with intent to distribute cocaine, in violation of 21 U.S.C.A. § 841(a)(1) (West 1999). Ray received a seventy-two month prison term. Ray’s attorney has filed a brief in accordance with Anders v. California , 386 U.S. 738 (1967). Counsel states that there are no meritorious grounds for appeal but raises two issues: (1)whether Ray waived his right to an appeal; and (2) whether the district court erred applying the sentencing guidelines. Ray has also filed a supplemental pro se brief raising additional issues. We dismiss the appeal based upon Ray’s waiver of appellate rights contained in his plea agreement. A defendant whose plea agreement contains an express waiver of the right to appeal may not appeal his sentence unless the waiver is shown to be unknowing or involuntary. United States v. Brown , 232 F.3d 399, 403 (4th Cir. 2000); see also United States v. Marin , 961 F.2d 493, 496 (4th Cir. 1992). Ray’s plea agreement contained a waiver of appellate rights. Our review of the plea agreement and the record of the plea colloquy reveal that Ray’s waiver was knowing andvoluntary. The sentence did not exceed the statutory maximum penalty, and there is no evidence that it was based on a constitutionally impermissible factor. Marin , 961 F.2d at 496. Moreover, the sentence was not imposed pursuant to proceedings conducted in violation of Ray’s right to counsel. United States v. Attar , 38 F.3d 727, 732-33 (4th Cir. 1994). We therefore dismiss his appeal. As required by Anders , we have reviewed the record and conclude that there are no meritorious issues for appeal. This court requires that counsel inform his client, in writing, of his right to petition the Supreme Court of the United States for further review. If the clientrequests that a petition be filed, but counsel believes that such a petition would be frivolous, then counsel may move in this court for leave to withdraw from representation. Counsel’s motion must state that acopy thereof was served on the client. We dispense with oral argument because the facts and legal contentions are adequately presented 2 U NITED S TATES v. R AYin the materials before the court and argument would not aid the decisional process.
DISMISSED 3 U NITED S TATES v. R AY
<PAGE>   1
                                                                    Exhibit 12



                           Ugly Duckling Corporation
                       Ratio Of Earnings to Fixed Charges

<TABLE>
<CAPTION>
(dollar amounts in thousands)             1997         1996         1995         1994          1993
                                          ----         ----         ----         ----          ----
<S>                                     <C>           <C>         <C>         <C>           <C>
Fixed Charges:
  Interest expense                      $ 5,260       $5,262      $ 5,956       $ 3,037      $   893
  Capitalized interest                      229            0           54           142            0
  Interest factor in rent expense (1)     1,764          790          784           462          161
                                        -------       ------      -------       -------      -------
                                        $ 7,253       $6,052      $ 6,794       $ 3,641      $ 1,054
                                        =======       ======      =======       =======      =======

Earnings:
  Earnings (Loss) from operations       $16,024       $ 5,966     $(3,972)      $(2,301)     $   728
  Fixed charges                           7,253         6,052       6,794         3,641        1,054
                                        -------       -------     -------       -------      -------
                                        $23,277       $12,018     $ 2,822       $ 1,340      $ 1,782
                                        =======       =======     =======       =======      =======

Ratio of Earnings to fixed charges         3.21          1.99        0.42 (2)      0.37 (2)     1.69
                                        =======       =======     =======       =======      =======
</TABLE>


(1) One-third of rent expense is deemed to be representative of the interest
    factor.
(2) Earnings are inadequate to cover fixed charges. The deficiency in 1994 and
    1995 was $2,301 and $3,972, respectively.
```

[Congressional Bills 104th Congress]
[From the U.S. Government Publishing Office]
[S. 2150 Introduced in Senate (IS)]

104th CONGRESS
  2d Session
                                S. 2150

  To prohibit extension or establishment of any national monument on 
  public land without full compliance with the National Environmental 
   Policy Act and the Endangered Species Act, and an express Act of 
                   Congress, and for other purposes.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                           September 27, 1996

  Mr. Murkowski (for himself, Mr. Craig, Mr. Hatch, Mr. Bennett, Mr. 
   Campbell, Mr. Burns, Mr. Nickles, and Mr. Stevens) introduced the 
 following bill; which was read twice and referred to the Committee on 
                     Energy and Natural Resources.

_______________________________________________________________________

                                 A BILL

 
  To prohibit extension or establishment of any national monument on 
  public land without full compliance with the National Environmental 
   Policy Act and the Endangered Species Act, and an express Act of 
                   Congress, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Public Lands Protection Act of 
1996''.

SEC. 2. LIMITATION ON EXTENSION OR ESTABLISHMENT OF NATIONAL MONUMENTS.

    The Act entitled ``An Act for the preservation of American 
antiquities'', approved June 8, 1906 (16 U.S.C. 431 et seq.), is 
amended by adding at the end the following:

``SEC. 5. LIMITATION ON EXTENSION OR ESTABLISHMENT OF NATIONAL 
              MONUMENTS.

    ``Notwithstanding section 2, no extension or establishment of a 
national monument may be undertaken on public land after the date of 
enactment of this section without full compliance with the National 
Environmental Policy Act and the Endangered Species Act, and an express 
Act of Congress.''.
                                 <all>
```
EXHIBIT 32.1



CERTIFICATION OF CHIEF EXECUTIVE OFFICER



Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of
Orion Acquisition Corp. II (the Company) hereby certifies, to such officers knowledge, that:



(i) the accompanying amended Annual Report on Form 10-KSB/A of the Company for the fiscal year ended December 31, 2004 (the
Report) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and



(ii) the information contained in the report fairly presents, in all material respects, the financial
condition and results of operations of the Company.



Date: May 2, 2005



|       |  |                                      
|------ |  | -------------------------------------
|       |  | /s/    DAVID T. HUNG,
M.D.           
|Name:  |  | David T. Hung, M.D.                  
|Title: |  | President and Chief Executive Officer



The foregoing
certification is being furnished solely to accompany the report pursuant to 18 U.S.C. § 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into
any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
```

[Federal Register Volume 89, Number 22 (Thursday, February 1, 2024)]
[Notices]
[Page 6529]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-01961]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

National Center for Advancing Translational Sciences; Notice of 
Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Center for Advancing Translational 
Sciences Special Emphasis Panel; R13 Conference Grant Review.
    Date: March 5, 2024.
    Time: 12:45 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Center for Advancing Translational Sciences, 
National Institutes of Health, One Democracy Plaza, 6701 Democracy 
Boulevard, Bethesda, MD 20892 (Video Assisted Meeting).
    Contact Person: Marilyn Moore-Hoon, Ph.D., Scientific Review 
Officer, Scientific Review Branch, National Center for Advancing 
Translational Sciences, National Institutes of Health, 6701 
Democracy Boulevard, MSC 4874, Bethesda, MD 20892, (301) 827-95549, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.859, 
Pharmacology, Physiology, and Biological Chemistry Research; 93.350, 
B--Cooperative Agreements; 93.859, Biomedical Research and Research 
Training, National Institutes of Health, HHS)

    Dated: January 26, 2024.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-01961 Filed 1-31-24; 8:45 am]
BILLING CODE 4140-01-P
```
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE ADVANCE
PARADIGM INC. FORM 10-K FOR THE YEAR ENDED MARCH 31, 1997 AND IS QUALIFIED IN
ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          MAR-31-1997
<PERIOD-START>                             APR-01-1996
<PERIOD-END>                               MAR-31-1997
<CASH>                                          51,086
<SECURITIES>                                         0
<RECEIVABLES>                                   35,485
<ALLOWANCES>                                       142
<INVENTORY>                                      1,859
<CURRENT-ASSETS>                                88,714
<PP&E>                                           8,868
<DEPRECIATION>                                   3,292
<TOTAL-ASSETS>                                 107,473
<CURRENT-LIABILITIES>                           63,850
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            78
<OTHER-SE>                                      42,450
<TOTAL-LIABILITY-AND-EQUITY>                   107,473
<SALES>                                              0
<TOTAL-REVENUES>                               251,562
<CGS>                                                0
<TOTAL-COSTS>                                  240,810
<OTHER-EXPENSES>                                 7,309
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             (1,181)
<INCOME-PRETAX>                                  4,624
<INCOME-TAX>                                     1,486
<INCOME-CONTINUING>                              3,138
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     3,138
<EPS-PRIMARY>                                      .39
<EPS-DILUTED>                                      .39
        

</TABLE>
**Exhibit 32.1**

 

CERTIFICATION OF THE CHIEF EXECUTIVE OFFICERPURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

 

The undersigned, the Chief Executive Officer of Gladstone CapitalCorporation (the “Company”), hereby certifies on the date hereof, pursuant to18 U.S.C. §1350(a), as adopted pursuant to Section 906 of TheSarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q for thequarter ended June 30, 2004 (“Form 10-Q”), filed concurrently herewith bythe Company, fully complies with the requirements of Section 13(a) orSection 15(d) of the Securities Exchange Act of 1934, as amended, and thatthe information contained in the Form 10-Q fairly presents, in all materialrespects, the financial condition and results of operations of the Company.

 

Dated:  August 10, 2004

 

 
| /s/ David Gladstone     |   |
|-------------------------|--------|
| David Gladstone         |
| Chief Executive Officer |

 

----